Targeting mast cells in inflammatory diseasesREBER, Laurent L; FROSSARD, Nelly.Pharmacology & therapeutics (Oxford). 2014, Vol 142, Num 3, pp 416-435, issn 0163-7258, 20 p.Article

A PIM₂ analogue suppresses allergic airway diseaseHARPER, Jacquie L; HAYMAN, Colin M; LARSEN, David S et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 2, pp 917-925, issn 0968-0896, 9 p.Article

bilastine (BILASKA°, INORIAL°) : Encore un antihistaminique H1, sans avantage = bilastine (BILASKA°, INORIAL°): Another H1 antihistaminic, without benefitLa Revue Prescrire. 2011, Vol 31, Num 338, issn 0247-7750, p. 894Article

Synthesis and evaluation of dimeric 1,2,3,4-Tetrahydro-naphthalenylamine and Indan-1-ylamine derivatives with mast cell-stabilising and anti-allergic activityBARLOW, James W; WALSH, John J.European journal of medicinal chemistry. 2010, Vol 45, Num 1, pp 25-37, issn 0223-5234, 13 p.Article

A simple synthesis of four stereoisomers of roseoside and their inhibitory activity on leukotriene release from mice bone marrow-derived cultured mast cellsYAJIMA, Arata; OONO, Yutaka; NAKAGAWA, Ryusuke et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 1, pp 189-194, issn 0968-0896, 6 p.Article

Structural determinants for histamine H₁ affinity, hERG affinity and QTc prolongation in a series of terfenadine analogsASLANIAN, Robert; PIWINSKI, John J; HEY, John A et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 17, pp 5043-5047, issn 0960-894X, 5 p.Article

Synthesis and pharmacological investigation of novel 4 -benzyl -1 -substituted -4H-[1,2,4 ]triazolo [4,3 -a]quinazolin -5 -ones as new class of H₁-antihistaminic agentsALAGARSAMY, V; SOLOMON, V. R; MURUGAN, M et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 12, pp 4009-4015, issn 0968-0896, 7 p.Article

Novel histamine H₃ receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffoldVACCARO, Wayne D; SHER, Rosy; WILLIAMS, Shirley M et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 2, pp 395-399, issn 0960-894X, 5 p.Article

Synthesis and pharmacological investigation of novel 1-substituted-4-phenyl-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones as a new class of H₁-antihistaminic agentsALAGARSAMY, Veerachamy; GIRIDHAR, Rajani; MANGAI RAM YADAV et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 7, pp 1877-1880, issn 0960-894X, 4 p.Article

Solution ophthalmique d'épinastine = Epinastine ophthalmic solutionThe Medical letter on drugs and therapeutics (Edition française). 2004, Vol 26, Num 11, pp 45-46, issn 0253-8512, 2 p.Article

Effects of second-generation histamine H₁ receptor antagonists on the sleep-wakefulness cycle in ratsSHIGEMOTO, Yuki; SHINOMIYA, Kazuaki; MIO, Mitsunobu et al.European journal of pharmacology. 2004, Vol 494, Num 2-3, pp 161-165, issn 0014-2999, 5 p.Article

Chimiokines et récepteurs de chimiokines : futures cibles dans le traitement des maladies allergiques = Chemokines and chemokine receptors: new targets for future therapy of allergic diseasesTONNEL, A. B; LELONG, J; GRIGORIU, B. D et al.Revue française d'allergologie et d'immunologie clinique. 2004, Vol 44, Num 1, pp 65-70, issn 0335-7457, 6 p.Article

Discovery of a new class of potent, selective, and orally active prostaglandin D₂ receptor antagonistsTORISU, Kazuhiko; KOBAYASHI, Kaoru; OHUCHIDA, Shuichi et al.Bioorganic & medicinal chemistry. 2004, Vol 12, Num 20, pp 5361-5378, issn 0968-0896, 18 p.Article

Effect of a topical steroid on gene expressions for chemokines in mice with contact hypersensitivityMITSUI, Gaku; HIRANO, Takeo; NIWANO, Yoshimi et al.International immunopharmacology. 2004, Vol 4, Num 1, pp 57-69, issn 1567-5769, 13 p.Article

Adrenal cortex function in asthmatic patients following the discontinuation of chronic therapy with systemic glucocorticosteroidsKOS-KUDŁA, B; CIESIELSKA-KOPACZ, N; OSTROWSKA, Z et al.Journal of clinical pharmacy and therapeutics (Print). 2003, Vol 28, Num 2, pp 103-108, issn 0269-4727, 6 p.Article

Cinnarizine is a useful and well-tolerated drug in the treatment of acquired cold urticaria (ACU)TOSONI, Cinzia; LODI-RIZZINI, Fabio; BETTONI, Lucia et al.EJD. European journal of dermatology. 2003, Vol 13, Num 1, pp 54-56, issn 1167-1122, 3 p.Article

Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposureHORAK, F; STÜBNER, P; ZIEGLMEYER, R et al.Allergy (Copenhagen). 2003, Vol 58, Num 6, pp 481-485, issn 0105-4538, 5 p.Article

Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthmaCURRIE, G. P; SYME-GRANT, N. J; MCFARLANE, L. C et al.Allergy (Copenhagen). 2003, Vol 58, Num 7, pp 602-607, issn 0105-4538, 6 p.Article

Efficacy of liposomal budesonide in experimental asthmaKONDURI, Kameswari S; NANDEDKAR, Sandhya; DÜZGÜNES, Nejat et al.Journal of allergy and clinical immunology. 2003, Vol 111, Num 2, pp 321-327, issn 0091-6749, 7 p.Article

Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitisWAHN, Ulrich; MELTZER, Eli O; POTTER, Paul et al.Journal of allergy and clinical immunology. 2003, Vol 111, Num 4, pp 763-769, issn 0091-6749, 7 p.Article

Inhibition of mast cell leukotriene release by thiourea derivativesVENKATACHALAM, Taracad K; QAZI, Sanjive; SAMUEL, Peter et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 3, pp 485-488, issn 0960-894X, 4 p.Article

Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppressionKALINER, Michael A; WHITE, Martha V; ECONOMIDES, Athena et al.Annals of allergy, asthma, & immunology. 2003, Vol 90, Num 6, pp 629-634, issn 1081-1206, 6 p.Article

Loratadine en vente libre (OTC) = Over the counter loratadineThe Medical letter on drugs and therapeutics (Edition française). 2003, Vol 25, Num 3, pp 11-12, issn 0253-8512, 2 p.Article

Systemic availability and lung deposition of budesonide via three different nebulizers in adultsDAHLSTRÖM, Kerstin; THORSSON, Lars; LARSSON, Per et al.Annals of allergy, asthma, & immunology. 2003, Vol 90, Num 2, pp 226-232, issn 1081-1206, 7 p.Article

Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpuraPERROTTA, Silverio; AMENDOLA, Giovanni; LOCATELLI, Franco et al.British journal of haematology. 2003, Vol 121, Num 1, pp 143-147, issn 0007-1048, 5 p.Article